TREM2 and neoplasm: By playing a part in tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs), TREM2 participated in facilitating an immune-suppressive TME in numerous cancers, including lung cancer, gastric cancer, and glioma [11–13].